DPCA 1-2 full issue
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
NOW<br />
PBS LISTED<br />
Introducing<br />
The fixed dose combination of<br />
JARDIANCE ® + metformin 1<br />
(empagliflozin)<br />
JARDIAMET ® and JARDIANCE ® ,<br />
Now PBS listed for: 2<br />
✔ Dual therapy<br />
(empagliflozin + metformin OR SU)<br />
✔ Triple therapy<br />
(empagliflozin + metformin AND SU)<br />
NEW<br />
✔ Add-on to insulin<br />
NEW<br />
INSULIN<br />
DUAL<br />
PBS<br />
LISTED<br />
TRIPLE<br />
Fictitious patient<br />
JARDIANCE ® is an SGLT2 inhibitor for adult patients<br />
with inadequately controlled type 2 diabetes. 3<br />
THAT SOUNDS<br />
GOOD TO<br />
DOCTOR<br />
PBS Information: JARDIANCE ® and JARDIAMET JARDIANCE ® : Authority ® is Required an SGLT2 inhibitor (STREAMLINED). for adult patients<br />
with inadequately controlled type 2 diabetes.<br />
Type 2 Diabetes. Refer to PBS Schedule for <strong>full</strong> Authority Required Information.<br />
3<br />
BEFORE PRESCRIBING, PLEASE REVIEW THE FULL PRODUCT INFORMATION WHICH IS AVAILABLE FROM<br />
WWW.BOEHRINGER-INGELHEIM.COM.AU/PI<br />
JARDIANCE ® PI<br />
JARDIAMET ® PI<br />
References: 1. JARDIAMET ® Product Information. 22 February 2016. 2. Schedule of Pharmaceutical Benefits. Available at: www.pbs.gov.au. Accessed March 2016. 3. JARDIANCE ®<br />
Product Information. 18 March 2016.<br />
Boehringer Ingelheim Pty Limited, ABN 52 000 452 308.<br />
78 Waterloo Road, North Ryde, NSW 2113 Australia. Copyright © 2016.<br />
ELI3690_ET_FP AU/EMP/00093d Prepared March 2016.<br />
Eli Lilly Australia Pty Limited, ABN 39 000 233 992.<br />
112 Wharf Road, West Ryde, NSW 2114 Australia.<br />
Copyright © 2016